Germany In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Published : Dec-2017

No. of Pages : 649

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 10
2 Introduction 15
2.1 What Is This Report About? 15
2.2 In Vitro Diagnostics (IVD) Market Segmentation 15
2.3 Definitions of Markets Covered in the Report 19
3 In Vitro Diagnostics Market, Germany 42
3.1 In Vitro Diagnostics Market, Germany, Revenue ($m), 2010-2024 42
3.2 In Vitro Diagnostics Market, Germany, Revenue Mix ($m), 2017 44
3.3 In Vitro Diagnostics Market, Germany, Category Contribution by Revenue ($m), 2017 45
3.4 In Vitro Diagnostics Market, Germany, Category Comparison by Revenue ($m), 2009-2023 47
3.5 In Vitro Diagnostics Market, Germany, Revenue ($m), 2010-2017 49
3.6 In Vitro Diagnostics Market, Germany, Revenue ($m), 2017-2024 51
3.7 In Vitro Diagnostics Market, Germany, Volume (Units), 2010-2024 53
3.8 In Vitro Diagnostics Market, Germany, Volume (Units), 2010-2017 55
3.9 In Vitro Diagnostics Market, Germany, Volume (Units), 2017-2024 57
3.10 In Vitro Diagnostics Market, Germany, Company Share by Revenue ($m), 2017 59
4 Clinical Chemistry Market, Germany 61
4.1 Clinical Chemistry Market, Germany, Revenue Mix ($m), 2017 61
4.2 Clinical Chemistry Market, Germany, Segment Contribution (%), 2017 62
4.3 Clinical Chemistry Market, Germany, Revenue ($m), 2010-2017 64
4.4 Clinical Chemistry Market, Germany, Revenue ($m), 2017-2024 66
4.5 Clinical Chemistry Market, Germany, Volume (Units), 2010-2017 100
4.6 Clinical Chemistry Market, Germany, Volume (Units), 2017-2024 102
4.7 Clinical Chemistry Market, Germany, Distribution Share by Revenue ($m), 2017 128
4.8 Clinical Chemistry Market, Germany, Company Share by Revenue ($m), 2017 129
5 Genetic Testing Market, Germany 131
5.1 Genetic Testing Market, Germany, Revenue Mix ($m), 2017 131
5.2 Genetic Testing Market, Germany, Segment Contribution (%), 2017 132
5.3 Genetic Testing Market, Germany, Revenue ($m), 2010-2017 133
5.4 Genetic Testing Market, Germany, Revenue ($m), 2017-2024 135
5.5 Genetic Testing Market, Germany, Distribution Share by Revenue ($m), 2017 137
5.6 Genetic Testing Market, Germany, Company Share by Revenue ($m), 2017 138
6 Hematology Market, Germany 140
6.1 Hematology Market, Germany, Revenue Mix ($m), 2017 140
6.2 Hematology Market, Germany, Segment Contribution (%), 2017 141
6.3 Hematology Market, Germany, Revenue ($m), 2010-2017 142
6.4 Hematology Market, Germany, Revenue ($m), 2017-2024 144
6.5 Hematology Market, Germany, Volume (Units), 2010-2017 170
6.6 Hematology Market, Germany, Volume (Units), 2017-2024 172
6.7 Hematology Market, Germany, Distribution Share by Revenue ($m), 2017 190
6.8 Hematology Market, Germany, Company Share by Revenue ($m), 2017 191
7 Histology And Cytology Market, Germany 193
7.1 Histology And Cytology Market, Germany, Revenue Mix ($m), 2017 193
7.2 Histology And Cytology Market, Germany, Segment Contribution (%), 2017 194
7.3 Histology And Cytology Market, Germany, Revenue ($m), 2010-2017 195
7.4 Histology And Cytology Market, Germany, Revenue ($m), 2017-2024 197
7.5 Histology And Cytology Market, Germany, Distribution Share by Revenue ($m), 2017 199
7.6 Histology And Cytology Market, Germany, Company Share by Revenue ($m), 2017 200
8 Immuno Chemistry Market, Germany 202
8.1 Immuno Chemistry Market, Germany, Revenue Mix ($m), 2017 202
8.2 Immuno Chemistry Market, Germany, Segment Contribution (%), 2017 203
8.3 Immuno Chemistry Market, Germany, Revenue ($m), 2010-2017 205
8.4 Immuno Chemistry Market, Germany, Revenue ($m), 2017-2024 207
8.5 Immuno Chemistry Market, Germany, Volume (Units), 2010-2017 241
8.6 Immuno Chemistry Market, Germany, Volume (Units), 2017-2024 243
8.7 Immuno Chemistry Market, Germany, Distribution Share by Revenue ($m), 2017 277
8.8 Immuno Chemistry Market, Germany, Company Share by Revenue ($m), 2017 278
9 Infectious Diagnostics Market, Germany 280
9.1 Infectious Diagnostics Market, Germany, Revenue Mix ($m), 2017 280
9.2 Infectious Diagnostics Market, Germany, Segment Contribution (%), 2017 281
9.3 Infectious Diagnostics Market, Germany, Revenue ($m), 2010-2017 283
9.4 Infectious Diagnostics Market, Germany, Revenue ($m), 2017-2024 286
9.5 Infectious Diagnostics Market, Germany, Volume (Units), 2010-2017 333
9.6 Infectious Diagnostics Market, Germany, Volume (Units), 2017-2024 336
9.7 Infectious Diagnostics Market, Germany, Distribution Share by Revenue ($m), 2017 383
9.8 Infectious Diagnostics Market, Germany, Company Share by Revenue ($m), 2017 384
10 Microbiology Culture Market, Germany 386
10.1 Microbiology Culture Market, Germany, Revenue Mix ($m), 2017 386
10.2 Microbiology Culture Market, Germany, Segment Contribution (%), 2017 387
10.3 Microbiology Culture Market, Germany, Revenue ($m), 2010-2017 389
10.4 Microbiology Culture Market, Germany, Revenue ($m), 2017-2024 391
10.5 Microbiology Culture Market, Germany, Distribution Share by Revenue ($m), 2017 401
10.6 Microbiology Culture Market, Germany, Company Share by Revenue ($m), 2017 402
11 Overview of Key Companies in Germany, In Vitro Diagnostics Market 404
11.1 F. Hoffmann-La Roche Ltd 404
11.2 Abbott Laboratories 404
11.3 Siemens Healthcare GmbH 404
11.4 Beckman Coulter Inc 404
11.5 Becton Dickinson and Co 405
11.6 Thermo Fisher Scientific Inc 405
11.7 bioMerieux SA 405
11.8 Sysmex Corp 405
11.9 Qiagen NV 406
11.10 Hologic Inc 406
11.11 Alere Inc 406
11.12 Bio-Rad Laboratories Inc 406
11.13 Ortho-Clinical Diagnostics Inc 407
11.14 DiaSorin S.p.A 407
11.15 Mindray Medical International Ltd 407
12 In Vitro Diagnostics Market Pipeline Products 408
13 Financial Deals Landscape 412
13.1 Acquisition 412
13.2 Asset Transactions 426
13.3 Debt Offerings 431
13.4 Equity Offerings 438
13.5 Partnerships 446
13.6 Private Equity 490
13.7 Venture Financing 491
14 Recent Developments 498
14.1 Corporate Communications 498
14.2 Financial Announcements 523
14.3 Government and Public Interest 576
14.4 Legal And Regulatory 580
14.5 Other Significant Developments 584
14.6 Product News 605
14.7 Strategy And Business Planning 624
15 Appendix 634
15.1 Research Methodology 635
15.2 GlobalData Consulting 639
15.3 Contact Us 640
15.4 Disclaimer 640

1.1 List of Tables
Table 1: In Vitro Diagnostics Market, Germany, Revenue ($m), USD Constant, 2010-2024 52
Table 2: In Vitro Diagnostics Market, Germany, Category Contribution by Revenue ($m), 2017 55
Table 3: In Vitro Diagnostics Market, Germany, Category Comparison by Revenue ($m), 2009-2023 57
Table 4: In Vitro Diagnostics Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 59
Table 5: In Vitro Diagnostics Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 61
Table 6: In Vitro Diagnostics Market, Germany, Volume (Units), 2010-2024 63
Table 7: In Vitro Diagnostics Market, Germany, Volume (Units), Historic, 2010-2017 65
Table 8: In Vitro Diagnostics Market, Germany, Volume (Units), Forecast, 2017-2024 67
Table 9: In Vitro Diagnostics Market, Germany, Company Share by Revenue ($m), USD Constant, 2017 69
Table 10: Clinical Chemistry Market, Germany, Segment Contribution (%), 2017 72
Table 11: Clinical Chemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 74
Table 12: Clinical Chemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 76
Table 13: Blood Test Strips - Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 78
Table 14: Clinical Chemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 80
Table 15: Enzyme Chemistry Reagents Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 82
Table 16: Feces Tests - Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 84
Table 17: Substrates Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 86
Table 18: Therapeutic Drug Monitoring Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 88
Table 19: Urine Analysis Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 90
Table 20: Urine Testing - Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 92
Table 21: Blood Test Strips - Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 94
Table 22: Clinical Chemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 96
Table 23: Enzyme Chemistry Reagents Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 98
Table 24: Feces Tests - Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 100
Table 25: Substrates Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 102
Table 26: Therapeutic Drug Monitoring Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 104
Table 27: Urine Analysis Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 106
Table 28: Urine Testing - Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 108
Table 29: Clinical Chemistry Market, Germany, Volume (Units), Historic, 2010-2017 110
Table 30: Clinical Chemistry Market, Germany, Volume (Units), Forecast, 2017-2024 112
Table 31: Blood Test Strips - Rapid Tests & POC Market, Germany, Volume (Units), Historic, 2010-2017 114
Table 32: Clinical Chemistry Analyzers Market, Germany, Volume (Units), Historic, 2010-2017 116
Table 33: Enzyme Chemistry Reagents Market, Germany, Volume (Units), Historic, 2010-2017 118
Table 34: Feces Tests - Rapid Tests & POC Market, Germany, Volume (Units), Historic, 2010-2017 120
Table 35: Substrates Market, Germany, Volume (Units), Historic, 2010-2017 122
Table 36: Urine Testing - Rapid Tests & POC Market, Germany, Volume (Units), Historic, 2010-2017 124
Table 37: Blood Test Strips - Rapid Tests & POC Market, Germany, Volume (Units), Forecast, 2017-2024 126
Table 38: Clinical Chemistry Analyzers Market, Germany, Volume (Units), Forecast, 2017-2024 128
Table 39: Enzyme Chemistry Reagents Market, Germany, Volume (Units), Forecast, 2017-2024 130
Table 40: Feces Tests - Rapid Tests & POC Market, Germany, Volume (Units), Forecast, 2017-2024 132
Table 41: Substrates Market, Germany, Volume (Units), Forecast, 2017-2024 134
Table 42: Urine Testing - Rapid Tests & POC Market, Germany, Volume (Units), Forecast, 2017-2024 136
Table 43: Clinical Chemistry Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2017 137
Table 44: Clinical Chemistry Market, Germany, Company Share by Revenue ($m), USD Constant, 2017 139
Table 45: Genetic Testing Market, Germany, Segment Contribution (%), 2017 141
Table 46: Genetic Testing Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 143
Table 47: Genetic Testing Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 145
Table 48: Genetic Testing Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2017 146
Table 49: Genetic Testing Market, Germany, Company Share by Revenue ($m), USD Constant, 2017 148
Table 50: Hematology Market, Germany, Segment Contribution (%), 2017 150
Table 51: Hematology Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 152
Table 52: Hematology Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 154
Table 53: Hematology Analyzers Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 156
Table 54: Hematology Cell Counters Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 158
Table 55: Hematology Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 160
Table 56: Hematology Reagents Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 162
Table 57: Hemostasis Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 164
Table 58: Immunohematology Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 166
Table 59: Hematology Analyzers Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 168
Table 60: Hematology Cell Counters Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 170
Table 61: Hematology Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 172
Table 62: Hematology Reagents Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 174
Table 63: Hemostasis Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 176
Table 64: Immunohematology Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 178
Table 65: Hematology Market, Germany, Volume (Units), Historic, 2010-2017 180
Table 66: Hematology Market, Germany, Volume (Units), Forecast, 2017-2024 182
Table 67: Hematology Analyzers Market, Germany, Volume (Units), Historic, 2010-2017 184
Table 68: Hematology Rapid Tests & POC Market, Germany, Volume (Units), Historic, 2010-2017 186
Table 69: Hematology Reagents Market, Germany, Volume (Units), Historic, 2010-2017 188
Table 70: Hemostasis Market, Germany, Volume (Units), Historic, 2010-2017 190
Table 71: Hematology Analyzers Market, Germany, Volume (Units), Forecast, 2017-2024 192
Table 72: Hematology Rapid Tests & POC Market, Germany, Volume (Units), Forecast, 2017-2024 194
Table 73: Hematology Reagents Market, Germany, Volume (Units), Forecast, 2017-2024 196
Table 74: Hemostasis Market, Germany, Volume (Units), Forecast, 2017-2024 198
Table 75: Hematology Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2017 199
Table 76: Hematology Market, Germany, Company Share by Revenue ($m), USD Constant, 2017 201
Table 77: Histology And Cytology Market, Germany, Segment Contribution (%), 2017 203
Table 78: Histology And Cytology Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 205
Table 79: Histology And Cytology Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 207
Table 80: Histology And Cytology Market, Germany, Distribution Share by Revenue ($m), USD Constant,2017 208
Table 81: Histology And Cytology Market, Germany, Company Share by Revenue ($m), USD Constant, 2017 210
Table 82: Immuno Chemistry Market, Germany, Segment Contribution (%), 2017 213
Table 83: Immuno Chemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 215
Table 84: Immuno Chemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 217
Table 85: Complement Deficiency Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 219
Table 86: Diabetes Assays Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 221
Table 87: Disease Specific Immunochemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 223
Table 88: Endocrinology Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 225
Table 89: IgE Allergy Blood Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 227
Table 90: Immunochemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 229
Table 91: Immunochemistry Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 231
Table 92: Vitamins Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 233
Table 93: Complement Deficiency Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 235
Table 94: Diabetes Assays Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 237
Table 95: Disease Specific Immunochemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 239
Table 96: Endocrinology Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 241
Table 97: IgE Allergy Blood Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 243
Table 98: Immunochemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 245
Table 99: Immunochemistry Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 247
Table 100: Vitamins Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 249
Table 101: Immuno Chemistry Market, Germany, Volume (Units), Historic, 2010-2017 251
Table 102: Immuno Chemistry Market, Germany, Volume (Units), Forecast, 2017-2024 253
Table 103: Complement Deficiency Tests Market, Germany, Volume (Units), Historic, 2010-2017 255
Table 104: Diabetes Assays Market, Germany, Volume (Units), Historic, 2010-2017 257
Table 105: Disease Specific Immunochemistry Market, Germany, Volume (Units), Historic, 2010-2017 259
Table 106: Endocrinology Tests Market, Germany, Volume (Units), Historic, 2010-2017 261
Table 107: IgE Allergy Blood Tests Market, Germany, Volume (Units), Historic, 2010-2017 263
Table 108: Immunochemistry Analyzers Market, Germany, Volume (Units), Historic, 2010-2017 265
Table 109: Immunochemistry Rapid Tests & POC Market, Germany, Volume (Units), Historic, 2010-2017 267
Table 110: Vitamins Tests Market, Germany, Volume (Units), Historic, 2010-2017 269
Table 111: Complement Deficiency Tests Market, Germany, Volume (Units), Forecast, 2017-2024 271
Table 112: Diabetes Assays Market, Germany, Volume (Units), Forecast, 2017-2024 273
Table 113: Disease Specific Immunochemistry Market, Germany, Volume (Units), Forecast, 2017-2024 275
Table 114: Endocrinology Tests Market, Germany, Volume (Units), Forecast, 2017-2024 277
Table 115: IgE Allergy Blood Tests Market, Germany, Volume (Units), Forecast, 2017-2024 279
Table 116: Immunochemistry Analyzers Market, Germany, Volume (Units), Forecast, 2017-2024 281
Table 117: Immunochemistry Rapid Tests & POC Market, Germany, Volume (Units), Forecast, 2017-2024 283
Table 118: Vitamins Tests Market, Germany, Volume (Units), Forecast, 2017-2024 285
Table 119: Immuno Chemistry Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2017 286
Table 120: Immuno Chemistry Market, Germany, Company Share by Revenue ($m), USD Constant, 2017 288
Table 121: Infectious Diagnostics Market, Germany, Segment Contribution (%), 2017 291
Table 122: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 293
Table 123: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 296
Table 124: Chlamydia trichomatis Diagnostic Test Kits Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 299
Table 125: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 301
Table 126: Hepatitis Test Kits Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 303
Table 127: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 305
Table 128: Infectious Diagnostics Multiple Parameter Test Kits Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 307
Table 129: Infectious Diagnostics Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 309
Table 130: Mycobacterium tuberculosis Diagnostic Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 311
Table 131: Polymerase Chain Reaction (PCR) Systems Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 313
Table 132: Post Streptococcus pyogenes Diagnostic Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 315
Table 133: Retrovirus Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 317
Table 134: Treponema pallidum Diagnostic Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 319
Table 135: Chlamydia trichomatis Diagnostic Test Kits Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 321
Table 136: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 323
Table 137: Hepatitis Test Kits Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 325
Table 138: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 327
Table 139: Infectious Diagnostics Multiple Parameter Test Kits Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 329

1.2 List of Figures
Figure 1: In Vitro Diagnostics Market, Germany, Revenue ($m), USD Constant, 2010-2024 51
Figure 2: In Vitro Diagnostics Market, Germany, Revenue Mix ($m), 2017 53
Figure 3: In Vitro Diagnostics Market, Germany, Category Contribution (%), 2017 54
Figure 4: In Vitro Diagnostics Market, Germany, Category Comparison by Revenue ($m), 2009-2023 56
Figure 5: In Vitro Diagnostics Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 58
Figure 6: In Vitro Diagnostics Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 60
Figure 7: In Vitro Diagnostics Market, Germany, Volume (Units), 2010-2024 62
Figure 8: In Vitro Diagnostics Market, Germany, Volume (Units), Historic, 2010-2017 64
Figure 9: In Vitro Diagnostics Market, Germany, Volume (Units), Forecast, 2017-2024 66
Figure 10: In Vitro Diagnostics Market, Germany, Company Share (%) 2017 68
Figure 11: Clinical Chemistry Market, Germany, Revenue Mix ($m), 2017 70
Figure 12: Clinical Chemistry Market, Germany, Segment Contribution (%), 2017 71
Figure 13: Clinical Chemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 73
Figure 14: Clinical Chemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 75
Figure 15: Blood Test Strips - Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 77
Figure 16: Clinical Chemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 79
Figure 17: Enzyme Chemistry Reagents Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 81
Figure 18: Feces Tests - Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 83
Figure 19: Substrates Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 85
Figure 20: Therapeutic Drug Monitoring Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 87
Figure 21: Urine Analysis Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 89
Figure 22: Urine Testing - Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 91
Figure 23: Blood Test Strips - Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 93
Figure 24: Clinical Chemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 95
Figure 25: Enzyme Chemistry Reagents Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 97
Figure 26: Feces Tests - Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 99
Figure 27: Substrates Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 101
Figure 28: Therapeutic Drug Monitoring Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 103
Figure 29: Urine Analysis Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 105
Figure 30: Urine Testing - Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 107
Figure 31: Clinical Chemistry Market, Germany, Volume (Units), Historic, 2010-2017 109
Figure 32: Clinical Chemistry Market, Germany, Volume (Units), Forecast, 2017-2024 111
Figure 33: Blood Test Strips - Rapid Tests & POC Market, Germany, Volume (Units), Historic, 2010-2017 113
Figure 34: Clinical Chemistry Analyzers Market, Germany, Volume (Units), Historic, 2010-2017 115
Figure 35: Enzyme Chemistry Reagents Market, Germany, Volume (Units), Historic, 2010-2017 117
Figure 36: Feces Tests - Rapid Tests & POC Market, Germany, Volume (Units), Historic, 2010-2017 119
Figure 37: Substrates Market, Germany, Volume (Units), Historic, 2010-2017 121
Figure 38: Urine Testing - Rapid Tests & POC Market, Germany, Volume (Units), Historic, 2010-2017 123
Figure 39: Blood Test Strips - Rapid Tests & POC Market, Germany, Volume (Units), Forecast, 2017-2024 125
Figure 40: Clinical Chemistry Analyzers Market, Germany, Volume (Units), Forecast, 2017-2024 127
Figure 41: Enzyme Chemistry Reagents Market, Germany, Volume (Units), Forecast, 2017-2024 129
Figure 42: Feces Tests - Rapid Tests & POC Market, Germany, Volume (Units), Forecast, 2017-2024 131
Figure 43: Substrates Market, Germany, Volume (Units), Forecast, 2017-2024 133
Figure 44: Urine Testing - Rapid Tests & POC Market, Germany, Volume (Units), Forecast, 2017-2024 135
Figure 45: Clinical Chemistry Market, Germany, Company Share (%) 2017 138
Figure 46: Genetic Testing Market, Germany, Revenue Mix ($m), 2017 140
Figure 47: Genetic Testing Market, Germany, Segment Contribution (%), 2017 141
Figure 48: Genetic Testing Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 142
Figure 49: Genetic Testing Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 144
Figure 50: Genetic Testing Market, Germany, Company Share (%) 2017 147
Figure 51: Hematology Market, Germany, Revenue Mix ($m), 2017 149
Figure 52: Hematology Market, Germany, Segment Contribution (%), 2017 150
Figure 53: Hematology Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 151
Figure 54: Hematology Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 153
Figure 55: Hematology Analyzers Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 155
Figure 56: Hematology Cell Counters Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 157
Figure 57: Hematology Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 159
Figure 58: Hematology Reagents Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 161
Figure 59: Hemostasis Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 163
Figure 60: Immunohematology Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 165
Figure 61: Hematology Analyzers Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 167
Figure 62: Hematology Cell Counters Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 169
Figure 63: Hematology Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 171
Figure 64: Hematology Reagents Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 173
Figure 65: Hemostasis Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 175
Figure 66: Immunohematology Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 177
Figure 67: Hematology Market, Germany, Volume (Units), Historic, 2010-2017 179
Figure 68: Hematology Market, Germany, Volume (Units), Forecast, 2017-2024 181
Figure 69: Hematology Analyzers Market, Germany, Volume (Units), Historic, 2010-2017 183
Figure 70: Hematology Rapid Tests & POC Market, Germany, Volume (Units), Historic, 2010-2017 185
Figure 71: Hematology Reagents Market, Germany, Volume (Units), Historic, 2010-2017 187
Figure 72: Hemostasis Market, Germany, Volume (Units), Historic, 2010-2017 189
Figure 73: Hematology Analyzers Market, Germany, Volume (Units), Forecast, 2017-2024 191
Figure 74: Hematology Rapid Tests & POC Market, Germany, Volume (Units), Forecast, 2017-2024 193
Figure 75: Hematology Reagents Market, Germany, Volume (Units), Forecast, 2017-2024 195
Figure 76: Hemostasis Market, Germany, Volume (Units), Forecast, 2017-2024 197
Figure 77: Hematology Market, Germany, Company Share (%) 2017 200
Figure 78: Histology And Cytology Market, Germany, Revenue Mix ($m), 2017 202
Figure 79: Histology And Cytology Market, Germany, Segment Contribution (%), 2017 203
Figure 80: Histology And Cytology Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 204
Figure 81: Histology And Cytology Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 206
Figure 82: Histology And Cytology Market, Germany, Company Share (%) 2017 209
Figure 83: Immuno Chemistry Market, Germany, Revenue Mix ($m), 2017 211
Figure 84: Immuno Chemistry Market, Germany, Segment Contribution (%), 2017 212
Figure 85: Immuno Chemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 214
Figure 86: Immuno Chemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 216
Figure 87: Complement Deficiency Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 218
Figure 88: Diabetes Assays Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 220
Figure 89: Disease Specific Immunochemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 222
Figure 90: Endocrinology Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 224
Figure 91: IgE Allergy Blood Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 226
Figure 92: Immunochemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 228
Figure 93: Immunochemistry Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 230
Figure 94: Vitamins Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 232
Figure 95: Complement Deficiency Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 234
Figure 96: Diabetes Assays Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 236
Figure 97: Disease Specific Immunochemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 238
Figure 98: Endocrinology Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 240
Figure 99: IgE Allergy Blood Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 242
Figure 100: Immunochemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 244
Figure 101: Immunochemistry Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 246
Figure 102: Vitamins Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 248
Figure 103: Immuno Chemistry Market, Germany, Volume (Units), Historic, 2010-2017 250
Figure 104: Immuno Chemistry Market, Germany, Volume (Units), Forecast, 2017-2024 252
Figure 105: Complement Deficiency Tests Market, Germany, Volume (Units), Historic, 2010-2017 254
Figure 106: Diabetes Assays Market, Germany, Volume (Units), Historic, 2010-2017 256
Figure 107: Disease Specific Immunochemistry Market, Germany, Volume (Units), Historic, 2010-2017 258
Figure 108: Endocrinology Tests Market, Germany, Volume (Units), Historic, 2010-2017 260
Figure 109: IgE Allergy Blood Tests Market, Germany, Volume (Units), Historic, 2010-2017 262
Figure 110: Immunochemistry Analyzers Market, Germany, Volume (Units), Historic, 2010-2017 264
Figure 111: Immunochemistry Rapid Tests & POC Market, Germany, Volume (Units), Historic, 2010-2017 266
Figure 112: Vitamins Tests Market, Germany, Volume (Units), Historic, 2010-2017 268
Figure 113: Complement Deficiency Tests Market, Germany, Volume (Units), Forecast, 2017-2024 270
Figure 114: Diabetes Assays Market, Germany, Volume (Units), Forecast, 2017-2024 272
Figure 115: Disease Specific Immunochemistry Market, Germany, Volume (Units), Forecast, 2017-2024 274
Figure 116: Endocrinology Tests Market, Germany, Volume (Units), Forecast, 2017-2024 276
Figure 117: IgE Allergy Blood Tests Market, Germany, Volume (Units), Forecast, 2017-2024 278
Figure 118: Immunochemistry Analyzers Market, Germany, Volume (Units), Forecast, 2017-2024 280
Figure 119: Immunochemistry Rapid Tests & POC Market, Germany, Volume (Units), Forecast, 2017-2024 282
Figure 120: Vitamins Tests Market, Germany, Volume (Units), Forecast, 2017-2024 284
Figure 121: Immuno Chemistry Market, Germany, Company Share (%) 2017 287
Figure 122: Infectious Diagnostics Market, Germany, Revenue Mix ($m), 2017 289
Figure 123: Infectious Diagnostics Market, Germany, Segment Contribution (%), 2017 290
Figure 124: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 292
Figure 125: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 295

Filed in: In Vitro Diagnostic, Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026 “The global in vitro fertilization market size is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1 % during the forecast period” The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain e......	$4950
Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact) Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) Summary Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area. The model discusses in detail the impact of COVID-19 on Assisted Reproductive Technology Devices market for the year 2020 and beyond. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat infertile women to achieve pregnancy. For decades now across much of the developed world, several techniques of ART have been in use with varying pregnancy success rates. These techniques primarily include, but are no......	$7500
Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Multiparameter CT/NG NAAT Tests market for the year 2020 and beyond. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic preg......	$7500
Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028 Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028 Summary Hemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively. Patients can be categorized as mild, moderate or severe depending on the percentage of circulating FVIII or FIX in their blood. Patients can be treated either on-demand or prophylactically using plasma-derived or recombinant replacement factors, the current standard of care. Although these therapies are effective, they are associated with a great treatment burden. There is a significant unmet need for new therapies that can reduce the great treatment burden associated with intravenous administration, the frequency of prophylactic infusions, and the risk of developing neutralizing a......	$10995
Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human Immunodeficiency Virus (HIV) has become one of the world's most serious health issues affecting approximately 36.9 million people. The epidemiology of HIV infections varies from one geographical region to another. Sources indicate that in many countries, incidence rates for HIV have stabilized due to the campaigns that provide condoms, pre-exposure prophylaxis, sterile needles, syringes, antiretroviral therapy (ART), and prevention of mother-to-child transmission interv......	$7500
Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia trachomatis. Patient access to Chlamydia screening, and thus the number of reported cases, varies substantially between countries. In some countries annual screening is recommended for specific patient groups deemed to be at higher risk of contracting the disease, such as sexually active females younger than 25 years. Additionally, screening of pregnant women for Chlamydia Trachomatis infections is currently recomme......	$7500
EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Globally, lung cancer is the second most common cancer in men and the third most common cancer in women. There are two main types of lung cancer; small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with NSCLC accounting for approximately 80-90% of all lung cancer cases. The 5-year survival rate for patients with stage IV disease is less than 5% as majority of patients present with the advanced or metastatic disease at diagnosis. EGFR is a member of the receptor tyrosine kinase family and a major factor in regulating ......	$7500
Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cervical cancer screening has traditionally been based on cervical cytology. In recent years however, many countries have incorporated Human Papilloma Virus (HPV) tests into their cervical cancer and pre-cancer screening programs. Cytology based screening programs require a well-established healthcare infrastructure for processing and interpretation of samples. It is hoped that HPV screening methods may enable better prevention of these disease, these devices are also highly sensitive an......	$7500
Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model "Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cytomegalovirus (CMV) represents the most common congenital, viral infection in the developed world and awareness of this disease is increasing. Few countries have official guidelines in place for CMV screening but in general testing tends to be performed for sperm donations, immunocompromised cases, and pregnant women. Diagnosis of CMV infections is complex as symptoms are often non-specific and mimic mononucleosis or the flu. Approximately 21-25% of primary CMV infections are symptomatic ......	$7500
Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Prenatal Screening is now routinely used in developed countries for early detection of fetal abnormalities. Various biochemical analytes are measured during the first or second trimester including free-beta human chorionic gonadotropin (hCG), total hCG, pregnancy associated plasma protein-A (PAPP-A), Alpha-fetoprotein (AFP), unconjugated estriol (uE3), and Inhibin A. These markers are used to screen for Down syndrome (Trisomy 21) as well as Edwards syndrome (Trisomy 18) and ectopic pregnancy. Additionally, maternal s......	$7500

Germany In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026

Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact)

Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028

Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model